Published Paper Details:

It is predicted that about 95% of adverse drug reactions (ADRs) never get reported after pharmacotherapy, necessitating strategies to improve ADR reporting. The introduction of databases like VigiAccess, in which ADR data from Pharmacovigilance centers all over the world can be assessed, is a key step toward strengthening ADR reporting. This study evaluated ADR reporting patterns in VigiAccess, an open-access pharmacovigilance database, as well as the therapeutic treatment of respiratory tract infections in patients from the Delhi-NCR region. A questionnaire was used to gather information mostly on the patients with respiratory tract infections. Additionally, a comprehensive search of VigiAccess was conducted to find the categories of reported ADRs as well as the quantity and variety of ADRs reported for a few chosen medications utilized in the therapy. VigiAccess was thoroughly searched, and seven primary kinds of reported ADRs were found in the database. These included illnesses affecting the skin, subcutaneous tissues, gastrointestinal system, mental system, respiratory, thoracic, and mediastinal systems, general disorders, and problems at the administration site. To reduce morbidity and mortality caused by ADRs, diligent ADR monitoring is required, which necessitates more research on a wider population. This study showed that tracking medications that affect the respiratory system and their associated adverse drug reactions might help with quality improvement efforts and perhaps enhance patient care.